Literature DB >> 20157991

Persistent vegetative and minimally conscious states.

Calixto Machado1, Julius Korein.   

Abstract

The diagnosis and management of patients with persistent vegetative (PVS) and minimally conscious (MCS) states entail powerful medical, ethical and legal debates. The recent description of the MCS highlights the crucial role of unexpected and well-documented recoveries of cognitive functions. Functional neuroimaging has provided new insights for assessing neuropathology and cerebral activity in these patients, providing information on the presence, degree, and location of any residual brain function in patients with PVS or MCS. We present a review on this topic, emphasizing the clinical and neuroimaging assessment of these states, with some of our recent results in this area. We conclude that the development of rehabilitation techniques for patients with PVS and others suffering long-lasting effects of brain injury is a crucial challenge for actual and future generations of neuroscientists.

Entities:  

Mesh:

Year:  2009        PMID: 20157991     DOI: 10.1515/revneuro.2009.20.3-4.203

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  3 in total

1.  Neural correlates of contents and levels of consciousness.

Authors:  Morten Overgaard; Rikke Overgaard
Journal:  Front Psychol       Date:  2010-10-15

Review 2.  Eye movement measurement in diagnostic assessment of disorders of consciousness.

Authors:  Windsor Kwan-Chun Ting; Jose Luis Perez Velazquez; Michael D Cusimano
Journal:  Front Neurol       Date:  2014-07-29       Impact factor: 4.003

3.  Assessing learning as a possible sign of consciousness in post-coma persons with minimal responsiveness.

Authors:  Giulio E Lancioni; Andrea Bosco; Marta Olivetti Belardinelli; Nirbhay N Singh; Mark F O'Reilly; Jeff Sigafoos; Francesca Buonocunto; Jorge Navarro; Crocifissa Lanzilotti; Fiora D'Amico; Marina De Tommaso
Journal:  Front Hum Neurosci       Date:  2014-02-10       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.